In which gestational weeks is Hegar's sign typically observed?
For uterine prolapse in pregnancy, a ring pessary can be inserted up to?
In a 5-month pregnant female, which of the following statements regarding physiological changes is true?
What is the typical pH of the vagina in a pregnant woman?
Tdap vaccine is given in between which weeks of pregnancy?
What is the energy requirement in late pregnancy?
Which structure do cytotrophoblasts invade during implantation?
Which screening test is not performed in pregnant women?
All of the following are physiological changes that occur during pregnancy, except which of the following?
Additional protein and calorie requirements in pregnancy are?
Explanation: ***6 to 10 weeks*** - **Hegar's sign** is a softening of the lower uterine segment, which is a probable sign of pregnancy detected during a **bimanual examination**. - This softening typically becomes noticeable and palpable between **6 and 10 weeks of gestation** due to increased vascularity and edema in the area. *10-14 weeks* - While the uterus continues to soften and enlarge, **Hegar's sign** is usually established earlier, making it less specific or prominent for confirmation in this later window. - At this stage, other signs of pregnancy, such as a **palpable fetal outline** or **fetal heart tones**, become more readily apparent. *14-18 weeks* - By this gestational period, the uterus is significantly larger and has risen out of the pelvic cavity, making the specific assessment of the **lower uterine segment's compressibility** as an isolated sign less relevant. - **Fetal movements** (quickening) may also be felt during this time, serving as a more direct indicator of pregnancy. *18-22 weeks* - At these later weeks, the uterus is distinctly enlarged, and much of the diagnosis relies on **fundal height assessment** and further monitoring of fetal development. - **Hegar's sign** is a very early sign of pregnancy and would not be used for confirmation in this advanced stage.
Explanation: ***18 weeks*** - A **ring pessary** can be effectively used for uterine prolapse in pregnancy up to **18 weeks** of gestation. - By this time, the uterus usually ascends into the abdominal cavity, naturally relieving the prolapse and making the pessary unnecessary. *12 weeks* - While a pessary can be inserted at this Gestational Age, this is not the **maximum effective period** for its use in relieving uterine prolapse. - The uterus is still largely pelvic at 12 weeks, and the pessary provides support, but the natural ascent that obviates its need hasn't fully occurred. *14 weeks* - This period is also within the effective range for pessary insertion but does not represent the **upper limit** of its utility. - The uterus is progressively becoming abdominal, but the full resolution of prolapse symptoms due to uterine ascent may still be some weeks away. *16 weeks* - While a pessary can certainly be used at this stage, it is not the **absolute limit** for its insertion. - The uterus is significantly larger and largely abdominal by 16 weeks, offering natural relief for many, but the critical 18-week mark is when the uterus is typically fully supported by the abdominal cavity.
Explanation: ***80-90% have soft systolic murmur*** - The **increased blood volume** and **cardiac output** during pregnancy lead to increased flow across the aortic and pulmonic valves, often resulting in a **physiological systolic ejection murmur**. - This murmur is typically heard best at the **left sternal border** and usually resolves after delivery. *Cardiac output is reduced* - **Cardiac output actually increases** significantly during pregnancy, typically by 30-50%, to meet the metabolic demands of the fetus and placenta. - This increase is due to both an **increase in heart rate** and **stroke volume**. *Systemic vascular resistance is increased* - **Systemic vascular resistance (SVR) decreases** during pregnancy, primarily due to the **vasodilating effects of progesterone** and the creation of a **low-resistance placental circulation**. - The drop in SVR contributes to the physiological **decrease in blood pressure** often observed in mid-pregnancy. *Increase in CVP* - **Central venous pressure (CVP) typically remains unchanged or slightly decreases** during normal pregnancy. - While blood volume increases, the accompanying **vasodilation and decreased SVR** usually prevent a significant rise in CVP.
Explanation: ***4.0*** - The typical vaginal pH in a pregnant woman is **acidic**, generally ranging from 3.5 to 4.5, with **4.0 being the most commonly cited average value** during pregnancy. - This **acidic environment** is crucial for maintaining a healthy vaginal flora, primarily dominated by **Lactobacillus species**, which produce lactic acid from glycogen deposits in vaginal epithelium. - The increased estrogen levels during pregnancy promote glycogen deposition, supporting lactobacilli growth and maintaining this acidic pH. *4.5* - While 4.5 is **also within the normal range** (3.5-4.5) for pregnant women, it represents the **upper limit** of normal vaginal pH during pregnancy. - Although still physiologic, **4.0 is more commonly referenced** as the typical value in obstetric literature, making it the best answer for "typical" pH. - A pH consistently at 4.5 or trending upward may warrant monitoring, though it is not necessarily pathological. *5* - A pH of 5 is considered **elevated** and is typically associated with conditions like **bacterial vaginosis** (BV) or **trichomoniasis**, which increase the risk of preterm labor and other complications. - A pH of 5 in pregnancy would raise suspicion and warrant further investigation, as it indicates a **less acidic** environment and disruption of normal lactobacilli-dominated flora. - This elevated pH suggests loss of the protective acidic environment. *>5* - A pH greater than 5 is **abnormal** for a pregnant woman and strongly suggests the presence of a **vaginal infection**, such as bacterial vaginosis, trichomoniasis, or aerobic vaginitis. - This **alkaline shift** favors the growth of pathogenic bacteria over beneficial lactobacilli, significantly increasing the risk of adverse pregnancy outcomes including preterm birth and chorioamnionitis. - Requires prompt evaluation and treatment.
Explanation: ***27-36 weeks*** - The **Tdap vaccine** is recommended during this window in **every pregnancy** to maximize the transfer of **maternal antibodies** to the fetus. - This timing provides effective protection against **pertussis (whooping cough)** for the newborn from birth until their own vaccinations begin. *10-16 weeks* - This period is generally too early for optimal **passive immunity transfer** to the fetus against pertussis. - While other vaccines might be considered, **Tdap is specifically timed later** for maximum antibody benefit. *17-22 weeks* - This window is also typically considered too early for the Tdap vaccine to provide the **highest level of antibody transfer** to the newborn. - The goal is to administer the vaccine when **maternal antibody levels peak closer to delivery**. *22-26 weeks* - While closer to the recommended timeframe, this still falls slightly outside the **optimal window (27-36 weeks)** for the Tdap vaccine. - Delaying slightly longer ensures **peak antibody levels** for the longest possible passive immunity.
Explanation: ***2500 calories*** - The energy requirement for women in late pregnancy (third trimester) is approximately **2300-2500 calories per day**, which includes an additional **300-450 calories** above pre-pregnancy needs. - This increased energy intake supports **fetal growth and development**, increased maternal blood volume, uterine growth, and the metabolic demands of pregnancy. - The **2500 calorie** recommendation represents the upper range suitable for most pregnant women with normal activity levels. *2000 calories* - This amount is closer to the **pre-pregnancy energy requirement** for an average woman, but is **insufficient** for late pregnancy. - During the third trimester, failing to meet increased caloric needs can compromise **fetal growth** and lead to **inadequate gestational weight gain**. *1400 calories* - This amount is **severely insufficient** for the increased metabolic demands of late pregnancy. - An inadequate calorie intake can compromise **fetal growth**, lead to **intrauterine growth restriction (IUGR)**, and cause **maternal nutrient deficiencies**. *3000 calories* - This caloric intake is generally **too high** for the average pregnant woman with normal activity levels. - Excessive intake is only justified in cases of **multiple gestation**, unusually high physical activity, or specific medical conditions. - Consuming 3000 calories per day without proper justification can lead to **excessive gestational weight gain**, gestational diabetes, and macrosomia.
Explanation: ***Decidua basalis*** - The **cytotrophoblasts** invade the maternal **decidua basalis**, which is the portion of the **endometrium** directly underlying the implanted embryo, forming the maternal component of the **placenta**. - This invasion is crucial for establishing the **placenta** and allowing for nutrient and waste exchange between the mother and the fetus. *Decidua parietalis* - The **decidua parietalis** is the portion of the **endometrium** lining the rest of the **uterine cavity**, not directly involved in the immediate implantation site. - It plays a role later in pregnancy, fusing with the **decidua capsularis** as the **embryo** grows. *Decidua capsularis* - The **decidua capsularis** is the portion of the endometrium that overlies the implanted embryo, separating it from the uterine lumen. - It does not undergo invasion by the **cytotrophoblasts** in the same way the **decidua basalis** does. *Decidua vera* - The **decidua vera** is another term for the **decidua parietalis**, referring to the endometrial lining of the uterine cavity that is not involved in the implantation site. - It is not directly invaded by **cytotrophoblasts** during implantation.
Explanation: ***Hep D*** - **Hepatitis D (HDV) screening is NOT routinely performed** in pregnant women, even in those who are HBsAg-positive. - While HDV can only infect those with Hepatitis B, **routine prenatal screening protocols do not include HDV testing**. - HDV testing may only be considered in specific scenarios such as **severe or fulminant hepatitis** in HBsAg-positive pregnant women, but it is not part of standard antenatal screening. - The **absence of routine HDV screening** reflects its low prevalence and the fact that management focuses primarily on HBV status. *VDRL* - The **Venereal Disease Research Laboratory (VDRL)** test is a **routine universal screening** test for **syphilis** during pregnancy. - Early detection and treatment of syphilis are crucial to prevent **congenital syphilis**, which can cause severe fetal and neonatal complications. - Screening is typically performed in the **first trimester** and may be repeated in the third trimester in high-risk populations. *Hep B* - **Hepatitis B surface antigen (HBsAg)** testing is a **universal screening recommendation** for all pregnant women. - This screening helps identify mothers who could transmit the virus to their infants during birth. - Positive mothers' infants receive **hepatitis B immunoglobulin (HBIG) and HBV vaccine** within 12 hours of birth to prevent vertical transmission. *Hep A* - **Hepatitis A screening** is not routinely performed in all pregnant women as a universal screening measure. - However, it **may be tested** in pregnant women with **specific risk factors** (travel to endemic areas, exposure history), **symptoms** (jaundice, elevated liver enzymes), or during outbreak investigations. - Unlike Hep D, Hep A testing has clinical utility in symptomatic cases and is more readily available in clinical practice.
Explanation: ***Decrease in renal plasma flow*** - This statement is incorrect because **renal plasma flow actually increases** significantly during pregnancy due to vasodilation. - The increased renal plasma flow contributes to the elevated **glomerular filtration rate** observed in pregnant women. *Increase in cardiac output* - **Cardiac output increases by 30-50%** during pregnancy to meet the metabolic demands of the growing fetus and maternal tissues. - This increase is primarily due to an increase in both **heart rate** and **stroke volume**. *Increase in glomerular filtration rate* - The **glomerular filtration rate (GFR) increases by 30-50%** during pregnancy, leading to increased renal clearance of waste products. - This physiologic change is partly due to the **increased renal plasma flow** and changes in renal hemodynamics. *Increase in blood volume* - **Blood volume increases by 30-50%** during pregnancy, with a proportionally greater increase in plasma volume compared to red blood cell mass. - This expansion in blood volume is crucial for meeting the demands of the uteroplacental circulation and protecting against hemorrhage during delivery.
Explanation: ***300 kcal/day calorie, 25 g/day protein*** - This option correctly states the typical **additional daily calorie and protein requirements** to support fetal growth and maternal physiological changes during pregnancy, especially during the second and third trimesters. - The **300 kcal/day** accounts for the increased metabolic rate and energy needed for tissue synthesis, while **25 g/day of protein** is crucial for fetal tissue development and maternal blood volume expansion. *60 kcal/day calorie, 12 g/day protein* - These values are **too low** to meet the significantly increased metabolic and growth demands of pregnancy. - Insufficient calorie and protein intake can lead to **poor fetal growth** and adverse pregnancy outcomes. *120 kcal/day calorie, 25 g/day protein* - While the protein requirement of **25 g/day** is appropriate, the **120 kcal/day** increase is still too low to support the full physiological demands of pregnancy. - This would not adequately cover the energy cost of tissue accretion and increased basal metabolic rate. *450 kcal/day calorie, 45 g/day protein* - These values represent an **excessive increase** in both calorie and protein intake for normal pregnancy. - Such high additional intake is generally **not recommended** for the average pregnant woman and could potentially contribute to excessive maternal weight gain or other complications.
Preconception Counseling
Practice Questions
Pregnancy Diagnosis and Dating
Practice Questions
Routine Antenatal Assessments
Practice Questions
Maternal Physiological Changes
Practice Questions
Nutrition in Pregnancy
Practice Questions
Screening Tests in Pregnancy
Practice Questions
Fetal Growth Assessment
Practice Questions
High-Risk Pregnancy Identification
Practice Questions
Antenatal Complications Management
Practice Questions
Psychosocial Aspects of Pregnancy
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free